⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181517 | 0.92 | — | — | |
| SCHEMBL181648 | 0.90 | SMN1; SMN2 (0.61) | — | |
| SCHEMBL9252238 | 0.90 | SMN1; SMN2 (0.61) | — | |
| SCHEMBL34843 | 0.83 | — | — | |
| SCHEMBL3455317 | 0.83 | MEN1 (0.56) | — | |
| Arcaine SCHEMBL303546 | 0.83 | MEN1 (0.62) | — | |
| Arcaine SCHEMBL11414566 | 0.80 | MEN1 (0.60) | — | |
| SCHEMBL3072659 | 0.80 | SMN1; SMN2 (0.67) | — | |
| SCHEMBL11882788 | 0.80 | SMN1; SMN2 (0.67) | — | |
| SCHEMBL3069140 | 0.80 | SMN1; SMN2 (0.67) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114276411-B | Solid phase synthesis method of cyclic peptide compound containing trithioether bond | 北京大学深圳研究生院 | 2024-02-09 | — | — | CN | claimed |
| WO-2023244536-A2 | OLIGONUCLEOTIDE ANALOGUE FORMULATIONS | NEUBASE THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | claimed |
| WO-2023225661-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-23 | — | — | WO | claimed |
| EP-4263491-A2 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NeuBase Therapeutics, Inc. (US) | 2023-10-25 | — | — | EP | claimed |
| US-20230174509-A1 | THERAPEUTIC USE OF PLEUROMUTILINS | ARIVA MED GMBH (AT) | 2023-06-08 | — | — | US | claimed |
| EP-4135683-A1 | THERAPEUTIC USE OF PLEUROMUTILINS | Nabriva Therapeutics GMBH (AT) | 2023-02-22 | — | — | EP | claimed |
| EP-4127228-A2 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NeuBase Therapeutics, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-2022261029-A2 | PEPTIDE NUCLEIC ACID THERAPEUTICS FOR TRINUCLEOTIDE REPEAT DISORDERS | NEUBASE THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | claimed |
| WO-2022261030-A1 | OLIGONUCLEOTIDE ANALOGUE MODULATORS OF ONCOGENES | NEUBASE THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | claimed |
| CN-115413238-A | Therapeutic use of pleuromutilin compounds | 纳布里瓦治疗有限责任公司 | 2022-11-29 | — | — | CN | claimed |
| WO-2001077097-A2 | POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-10-18 | — | — | WO | claimed |
| WO-2001068605-A1 | POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED BENZENES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-09-20 | — | — | WO | claimed |
| US-6251854-B1 | COMPRISING AN OLIGOPETIDE INCLUDING A GUANIDINIUM-CONTAINING AMINO ACID SUCH AS ARGININE, AND A COMPOUND SUCH AS 2H-3-(4-FLUOROBENZYL)-7-(BUT-2-YL)-8-(3-METHYLBUTYL)-DIAZOLIDINE(1,2 -B)DIHYDROIMIDAZOLE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-06-26 | — | — | US | claimed |
| WO-2000069833-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL URACILS AS ANTICOAGULATIVE AGENTS | PHARMACIA CORPORATION (US) | 2000-11-23 | — | — | WO | claimed |
| WO-2000069832-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRYMIDINONES USEFUL AS ANTICOAGULANTS | PHARMACIA CORPORATION (US) | 2000-11-23 | — | — | WO | claimed |
| WO-2000069826-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2000-11-23 | — | — | WO | claimed |
| WO-2000069834-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2000-11-23 | — | — | WO | claimed |
| WO-1998041223-A1 | N-METHYL-D-ASPARTATE RECEPTOR CHANNEL BLOCKERS AND METHOD FOR IDENTIFYING SUCH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-09-24 | — | — | WO | claimed |
| EP-0002534-B1 | AMINO ACID DERIVATIVES, PROCESS FOR OBTAINING THEM, INTERMEDIATE COMPOUNDS IN OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-01-13 | — | — | EP | claimed |
| EP-0031104-A1 | Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1981-07-01 | — | — | EP | claimed |